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Importance: Cognitive skills are known to decline through the lifespan with large
individual differences. The molecular mechanisms for this decline are incompletely
understood. Although leukocyte telomere length provides an index of cellular age
that predicts the incidence of age-related diseases, it is unclear whether there is an
association between cognitive decline and leukocyte telomere length.
Objective: To examine the association between changes in cognitive function during
adult life and leukocyte telomere length after adjusting for confounding factors such as
education, mental health and life style.
Design, Setting, and Participants: Two groups of men with negative (n = 97) and
positive (n = 93) change in cognitive performance were selected from a birth cohort of
1985 Danish men born in 1953. Cognitive performance of each individual was assessed
at age ∼20 and 56 years. Leukocyte telomere length at age ∼58 was measured using
qPCR. Linear regression models were used to investigate the association between
cognitive function and leukocyte telomere length.
Results: Men with negative change in cognitive performance during adult life had
significantly shorter mean leukocyte telomere length than men with positive change in
cognitive performance (unadjusted difference β = −0.09, 95% CI −0.16 to −0.02,
p = 0.02). This association remained significant after adjusting for smoking, alcohol
consumption, leisure time activity, body mass index (BMI) and cholesterol (adjusted
difference β = −0.09, 95% CI −0.17 to −0.01, p = 0.02) but was non-significant
after adjusting for smoking, alcohol consumption, leisure time activity, BMI, cholesterol,
current cognitive function, depression and education (adjusted difference β = −0.07,
95% CI −0.16 to −0.01, p = 0.08).
Conclusion and Relevance: Preclinical cognitive changes may be associated with
leukocyte telomere length.
Keywords: cognitive function, telomere length, mental health, birth cohort study, aging
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INTRODUCTION
Cognitive performance seems to decline during adult life under
the influence of genetic and environmental factors (Deary et al.,
2009; Tucker-Drob and Briley, 2014). It has been suggested
that cognitive decline is caused by a self-perpetuating cycle
of oxidative stress triggering neuroinflammation, which further
promotes oxidative stress as well as the suggested underlying
neurodegeneration and cell death (Cai et al., 2013). Recently,
cognitive decline was associated with leukocyte telomere length
(LTL) and the LTL is assumed to reflect the accumulated burden
of inflammation and oxidative stress occurring during the life
course (Eitan et al., 2014). This relationship may therefore be
influenced by same mechanisms such as oxidative stress and
inflammation but the association may also be bi-directional.
In a number of cross-sectional studies (outlined in
Supplementary Table 1), mainly among adults above 60
years, short LTL has been associated with cognitive impairment
(Valdes et al., 2010; Der et al., 2012; Ma et al., 2013). Other studies
have found no correlation between LTL and cognitive function
(Harris et al., 2006; Bendix et al., 2011, 2014a; Cohen-Manheim
et al., 2016). Furthermore, two cohort studies have found that
short LTL predicts cognitive decline (Martin-Ruiz et al., 2006;
Yaffe et al., 2011). In the Nurses’ Health Study, short LTL in
women above age 70 was modestly associated with subsequent
cognitive decline (Devore et al., 2011), and in 70–79 year old
adults from the Health ABC study short LTL predicted a 7
year decline in Mini Mental Test score (Yaffe et al., 2011). In
two cohort studies, however, cognitive decline did not predict
subsequent differences in LTL. In 70-year olds from the Lothian
1936 birth cohort, LTL at age 70 was not associated with cognitive
changes occurring between ages 11 and 70 (Harris et al., 2012),
nor was there any association between cognitive decline and LTL
in an Australian population-based study (Mather et al., 2010).
The previous cohort studies have examined the relationship
between LTL and cognitive decline in follow-ups of 2–7 years
(Martin-Ruiz et al., 2006; Mather et al., 2010; Devore et al., 2011;
Yaffe et al., 2011), mostly in persons above 70 years (Martin-Ruiz
et al., 2006; Devore et al., 2011; Yaffe et al., 2011; Harris et al.,
2012) (Supplementary Table 1). Thus, it remains uncertain as to
whether or not LTL is a marker of cognitive decline in early aging.
The aim of the present study was to examine the association
of change in cognitive function occurring between age ∼20 and
56 with LTL measured at age ∼58, as well as to investigate
the extent to which potentially confounding factors: smoking,
alcohol consumption, leisure time activity, Body Mass Index
(BMI), serum cholesterol, indicators of mental function and
education might influence any such association.
MATERIALS AND METHODS
Study Population
Participants were recruited from the Metropolit 1953 Danish
male birth cohort, which includes 11,532 men born in 1953 in
Copenhagen (Osler et al., 2009). These men were all cognitively
assessed at age ∼20 and again in 2009–10 at age ∼56 as part
of the Copenhagen Aging and Midlife Biobank project (CAMB)
(Avlund et al., 2014; Hansen et al., 2014). Among the 1985
members of the Metropolit cohort who had participated in
both cognitive tests, a linear regression analysis was carried out
with the cognitive test score at age ∼20 as single predictor
and the cognitive test score at age ∼56 as outcome. Each
individual’s standardized residual from the regression line was
considered a measure of the relative cognitive change between
the two tests for that particular individual. To ensure sufficient
variance in the magnitude of cognitive change, we invited the
participants with the largest positive residuals [termed group
1 (residual range 0.96–2.80)] and the largest negative residuals
[termed group 2 (residual range −2.83 to −0.99)] to participate
in the study. Outliers defined as individuals with standardized
residuals larger than 3 were excluded. In total, 552 participants
were invited by letter to participate in a neurophysiological
examination and blood sampling (249 in group 1; 303 in group
2). Based on participant interviews 36 persons were excluded
(abuse of alcohol or drugs, certain neurological disorders, certain
neurological, mental or psychiatric diagnoses, certain depressive
diseases, former traumatic brain injury or contraindication of
MR scanning). Of the remaining participants, 207 (102 in group
1; 105 in group 2) chose to participate in the examination period
from 2010 to 2013 (∼58 years). LTL was not measured for 13
participants (7 and 6 from group 1 and 2, respectively) (due
to lack of blood material or unknown reasons). One included
participant had a persistent depression (group 2). Within-
group comparisons of residuals showed no differences between
included participants, participants who were invited but did not
want to participate, and those who were excluded. The inclusion
procedure is described in detail in previous publications (e.g.,
Hansen et al., 2014).
The study was approved by the local ethical committee
(De Videnskabsetiske Komiteer for Region Hovedstaden). All
participants provided written informed consent. The study has
also been registered by the Danish Data Protection Agency.
Measurements
Cognitive Change
At age ∼20 years the participants completed the Danish draft
board intelligence test Børge Prien’s Prøve (BPP) as a part of the
draft board assessment program. The 45-min BPP test comprises
letter matrices, verbal analogies, number series, and geometric
figures. The score, which is the total number of correct answers
out of 78 questions, has proved to correlate to 0.82 with the
Wechsler Adult Intelligence Scale (Teasdale, 2009). In the CAMB
follow-up examination in 2009/2010 participants completed
a short version of the Intellegenz-Struktur-test 2000R (IST),
which matches the BPP test and comprises verbal analogies,
number series, and sentence completion (Osler et al., 2013;
Mortensen et al., 2014). Relative cognitive change was assessed by
standardized residual from regression analyses on the two tests as
described above in the section “Study population.”
Leukocyte Telomere length (LTL)
Non-fasting blood samples were collected during the
examination day. Buffy coat was prepared from whole
blood and DNA was purified using Maxwell system for
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automated extraction from buffy coat samples. DNA purity was
measured based on absorbance at 260 and 280 nm (NanoDrop
Spectrophotometer) and all samples had a 260/280 nm ratio of
1.8–2.0.
LTL measurement was carried out with an adaptation of the
qPCR methods described by Cawthon (2002, 2009). The method
is described and validated in more detail elsewhere (Bendix et al.,
2014b).
For measurement of telomere repeat copies (T),
primers Telg—5′ -ACACTAAGGTTTGGGTTTGGGTTT
GGGTTTGGGTTAGTGT-3′ and Telc—5′-TGTTAGGTATCCC
TATCCCTATCCCTATCCCTATCCCTAACA-3′ were used.
The single copy gene (S) chosen was TaqMan Copy Number
Reference Assay RNase P (Applied Biosystems Inc., CA, USA).
The qPCR was performed on a 7900HT Fast Real-Time PCR
System in 384-plates. Analyses were carried out using the
7900HT Sequence Detection System (SDS) version 2.3 (Applied
Biosystems INC., CA, USA). Cycling conditions for telomere
runs were 50◦C for 2 min, 95◦C for 2 min, followed by two cycles
of 95◦C for 15 s, 52◦C for 15 s, and 36 cycles of 95◦C for 15 s,
62◦C for 15 s, and 71◦C for 15 s. LTL was measured in T/S ratio.
LTL was measured twice in two independent batches (n = 95
group 1 and n= 99 group 2).
All the analyses presented in this paper were carried out
separately on each of the two telomere measurements (12 results
failed for one measurement and 4 results failed for the other
measurement). As the results were nearly identical only data for
one of the measurements is presented (n = 93 group 1 and n =
97 group 2).
Covariables
A clinical neurocognitive test battery was used to assess functions
proved to be sensitive to normal and pathological cognitive
decline related to aging. For this study we included the
Addenbrooke’s (ACE) test (Mathuranath et al., 2000), a brief
cognitive screening battery that is sensitive to mild cognitive
impairment. As depressive symptoms might influence cognitive
performance, data from the Major Depression Inventory (MDI),
which measures the frequency of 12 depressive symptoms over
the past 2 weeks (Bech et al., 2001) collected in the CAMB
study, were included. The two mental scores were analyzed
as continuous variables. In addition, covariables which have
been associated with cognitive decline and LTL (information
on vocational education, current smoking status, alcohol
consumption, physical activity during leisure, BMI and serum
cholesterol) were included in the analyses. These variables were
obtained in the CAMB examination in 2009-10 (participants aged
∼56 year).
Statistical Analysis
Differences in LTL and covariables between the two cognitive
groups were analyzed by t-test and univariate linear regression
models for categorical variables. We then conducted series
of multiple regression analyses to evaluate the individual and
mutually adjusted influences of the potentially confounding
covariables (smoking, alcohol consumption, leisure time activity,
BMI, serum cholesterol, MDI, ACE, and vocational education)
on the association between the two groups with different change
in cognitive function and LTL. In the first regression model
we included smoking, alcohol, leisure time activity, BMI and
cholesterol. Subsequently ACE and MDI were added while
vocational education was also included in the final model. The
basic assumption for linear regression [linearity, normality and
colinarity (Variance Inflation Factor)] was examined using the
diagnostic facilities in STATA.
RESULTS
Due to selection procedure, there was no difference between the
two groups on BPP scores (measured ∼20 years), but substantial
differences on the IST scores (measured ∼56 years). Group
2 also obtained lower ACE scores, had less education, higher
cholesterol and higher MDI depression scores, while there was
no difference between the groups with regard to prevalence of
smoking, sedentary leisure time activity, alcohol consumption
or BMI (Table 1).
Mean LTL measured at age ∼58 was shortest in group 2,
i.e., in the participants with negative residuals reflecting relative
cognitive decline (P < 0.01) (Table 1). The covariables were not
or only moderately associated with LTL (Table 1, last column).
In the regression model (Table 2) with LTL as outcome and
group as main predictor participants with negative change
in cognitive performance during adult life had shorter mean
LTL than did participants with positive change in cognitive
performance (unadjusted difference β = −0.09, 95% CI −0.16
to −0.02, p = 0.02). This association remained significant after
adjusting for smoking, alcohol consumption, leisure time activity,
BMI and cholesterol (adjusted difference β = −0.09, 95% CI
−0.17 to −0.01, p = 0.02) and a p-value of 0.05 was obtained
after adjusting for smoking, alcohol consumption, leisure time
activity, BMI, cholesterol, MDI and ACE (β = −0.08, 95% CI
−0.16 to −0.00, p = 0.05). Association was non-significant
after adjusting for smoking, alcohol consumption, leisure time
activity, BMI, cholesterol, current cognitive function, depression
and education (adjusted difference β = −0.07, 95% CI −0.16 to
−0.01, p= 0.08).
DISCUSSION
In the present study we investigated the association between age-
related change in cognitive function and LTL. In a sample of
middle-aged men selected on the basis of change in cognitive
function between age ∼20 and 56, LTL measured at age ∼58
was significantly shorter in the group with negative change in
cognitive function than it was in the group with a positive change.
This relationship attenuated after adjustment for education,
smoking, alcohol consumption, BMI, leisure time activity,
serum cholesterol and scores for current cognitive function and
depression. Repeated measurements of LTL were not available.
Therefore, association of cognitive decline and LTL measured at
different ages can’t be examined or whether cognitive decline
precede changes in LTL. Furthermore, the effect of the current
cognitive function measured by the ACE test on LTL compared
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TABLE 1 | Mean leukocyte telomere length (LTL) (age ∼58) and the distribution of covariables in 190 middle-aged men with positive (Group 1) and
negative (Group 2) cognitive change between age ∼20 and 56 years.
Positive cognitive change N = 93 Negative cognitive change N = 97 P-value* LTL mean (SD) P-value*
LTL (mean (SD)) 1.08 (0.28) 0.98 (0.24) P < 0.01
Percent smoking at age 56
Yes 18.3 16.5 1.06 (0.31)
No 81.7 83.5 P = 0.74 1.02 (0.25) P = 0.48
Percent with weekly alcohol
consumption above 21
drinks at age 56
Yes 20.4 22.6 1.00 (0.25)
No 79.6 77.3 P = 0.71 1.04 (0.26) P = 0.16
Percent Lower vocational
education at age 56
Yes 25.8 48.5 1.00 (0.27)
No 74.2 51.6 P < 0.01 1.05 (0.25) P = 0.15
Percent sedentary leisure
time activity at age 56
Yes 6.6 8.3 1.02 (0.22)
No 93.5 91.7 P = 0.65 1.03(0.26) P = 0.88
Body Mass Index (kg/m2) at
age 56 (mean (SD))
26.21 (3.63) 26.94 (3.40) P = 0.08 H 1.03 (0.28)
L 1.04 (0.24) P = 0.40
Serum cholesterol (mmol/l)
at age 56 (mean (SD))
5.30 (0.85) 5.54 (0.91) P = 0.03 H 1.04 (0.24)
L 1.02 (0.27) P = 0.86
MDI Depression score at
age 56 (mean (SD))
5.30 (4.75) 7.33 (7.74) P = 0.01 H 1.06 (0.27)
L 0.99 (0.24) P = 0.04
BPP test score at age 20
(mean (SD))
46.3 (9.8) 45.3 (8.2) P = 0.43 H 1.02 (0.27)
L 1.05 (0.24) P = 0.21
IST test score at age 56
(mean (SD))
42.7 (7.4) 21.1 (6.1) P < 0.01 H 1.00 (0.23)
L 1.07 (0.29) P = 0.05
ACE at age 58 (mean (SD)) 95.82 (3.35) 92.93 (4.66) P < 0.01 H 1.00 (0.23)
L 1.07 (0.29) P = 0.04
*From t- or chi-square test; H, highest 50%; L, lowest 50% of distribution of the covariables; BPP, Børge Priens Prøve; IST, Intelligenz-Struktur-Test 2000 R; MDI, Major Depression
Inventory; ACE, Addenbrooks cognitive test.
TABLE 2 | The relationship in beta-coefficient and 95% confidence intervals (CI) of negative cognitive change (Group 2) vs. positive cognitive change
(Group 1) between age ∼20 and 56 years with leukocyte telomere length (LTL) (age ∼58) in 190 middle-aged Danish men.
Beta-coefficient (95% CI) P-value
Negative cognitive change (group 2 vs. 1) −0.09 (−0.16 to −0.02) P = 0.02
Negative cognitive change group, adjusted for smoking, alcohol consumption, BMI, leisure time activity and cholesterol −0.09 (−0.17 to −0.01) P = 0.02
Negative cognitive change group, adjusted for smoking, alcohol consumption, BMI, leisure time activity, cholesterol, MDI
and ACE
−0.08 (−0.16 to −0.00) P = 0.05
Negative cognitive change group, adjusted for smoking, alcohol consumption, BMI, leisure time activity, cholesterol, MDI,
ACE and vocational education
−0.07 (−0.16 to −0.01) P = 0.08
BMI, Body Mass Index; MDI, Major Depression Inventory; ACE, Addenbrooks cognitive test.
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to the impact of cognitive changes over the life course on the
telomere length can’t be sufficiently concluded. These results
do not concur with another study in the literature of ∼1000
relatively healthy men and women from Scotland in which no
relationship was found between LTL and changes in cognitive
function over the life course (Harris et al., 2012). As noted by the
authors of this study, their population was socially homogenous
and the variance possibly too limited to detect any association.
Two other cohort studies with shorter follow-up times found
that short LTL predicted cognitive decline in old age (Devore
et al., 2011; Yaffe et al., 2011), while a previous study on geriatric
patients with amean age of 85 did not find that low LTL predicted
progression from normal to mild cognitive impairment after 2
years of follow-up (Zekry et al., 2010).
The direction of the association between cognition and
telomere length is unclear. The association may be bi-directional
or it may be caused by related underlying processes. As an
example increasing obesity is negatively correlated with cognitive
performance supported by both human clinical and animal
studies but the mechanisms have not been fully clarified.
Studies have suggested obesity to negatively impact cerebral
vascular function, hippocampal brain atrophy, blood-brain
barrier functions and inflammation contributing to cognitive
deficits (Nguyen et al., 2014). Furthermore, telomere length has
been suggested to be affected by obesity among other factors such
as smoking, physical activity, and alcohol consumption (Mather
et al., 2011). On the other hand, telomere length may impact
pulse pressure and the risk of stroke which in turn may lead to
cognitive impairment. An comprehensive causal explanation of
these associations and the importance of each involved factor
have not been fully clarified (Jeanclos et al., 2000;Waldstein et al.,
2008; Cai et al., 2013; Eitan et al., 2014; D’Mello et al., 2015).
The strength of the present study is that it was based on
prospectively collected data on cognitive performance in a
sample of men with no clinical signs of mental disorder or
dementia. To obtain sufficient variance, the two groups were
selected to consist of men with extreme residuals, i.e., those
with the most negative and positive relative change in cognitive
function. In order to account for variation in LTL measurements,
qPCR measurements were repeated in two independent batches.
Results from the analyses based on each of the twomeasurements
showed the same pattern of associations. The assessment of
cognitive function was conducted with two different tests at age
∼20 (BPP) and at age ∼56 (IST), but with an almost 40 year
retest interval a correlation of 0.70 has been observed between
the two tests in the larger cohort. This would suggest that errors
of measurement and differences between the two tests contribute
relatively little variance and that the residuals reflect true change
in global cognitive function (Osler et al., 2013). It would have
been advantageous for the present study if longitudinal LTL data
were available. Longitudinal LTL data would provide information
whether individual short telomere length was innate or had
in fact decreased during life due to for example inflammation
and oxidative stress. Moreover, repeated measurements of LTL
and of cognitive abilities across lifespan would provide valuable
insight into the onset and rate of changes as well as strength of
relationship between cognition and LTL at different stages of life.
Another limitation of the study is the measurement of
telomere length in a heterogeneous blood sample and the
used method doesn’t discriminate between telomere lengths in
different cell types or different chromosomes. It would have been
advantageous to measure telomere length in neural tissue such
as neurons or glial cells if materials like this were available. An
additional benefit for the study could be to measure telomere
length not just by one method to correct for PCR measurement
uncertainty.
A recent study based on the Jerusalem Lipid Research Clinic
study has examined longitudinal LTL data and association
with cognitive ability (Cohen-Manheim et al., 2016). The LTL
dynamics was measured over 13 years in young adults (measured
at ages 28–32 and 41–46 years) and compared with cognitive
function at ages 48–52. In this study increased LTL shortening
was found to be associated with poorer cognitive function.
However, another new study measuring telomere attrition and
cognitive function at later ages (from 70 to 76 years and from
79 to 92 years) did not find the rate of telomere attrition
to correlate with the rate of cognitive decline at these high
ages (Harris et al., 2016). The rate of LTL changes may
depend on different factors that vary across the life span
and telomere length dynamics may differ at different stages
in life. Therefore, it is likely that the association with age-
related cognitive decline will change according to the timing of
telomere analysis and age at cognitive assessment (Mather et al.,
2011).
In conclusion, our study suggests that preclinical cognitive
changes in middle-aged men are associated with LTL at age 58.
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